1. Boers, I, Muskiet, FAJ, Berkelaar, E, et al. (2014) Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: a randomized controlled pilot-study. Lipids Health Dis 13, 160.
2. Frassetto, LA, Schloetter, M, Mietus-Synder, M, et al. (2009) Metabolic and physiologic improvements from consuming a Paleolithic, hunter-gatherer type diet. Eur J Clin Nutr 63, 947–955.
3. Genoni, A, Lyons-Wall, P, Lo, J, et al. (2016) Cardiovascular, metabolic effects and dietary composition of ad-libitum Paleolithic v. Australian Guide to Healthy Eating Diets: a 4-week randomised trial. Nutrients 8, 314.
4. Jönsson, T, Granfeldt, Y, Ahrén, B, et al. (2009) Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. Cardiovasc Diabetol 8, 35.
5. Lindeberg, S, Jönsson, T, Granfeldt, Y, et al. (2007) A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 50, 1795–1807.
6. Mellberg, C, Sandberg, S, Ryberg, M, et al. (2014) Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial. Eur J Clin Nutr 68, 350–357.
7. Osterdahl, M, Kocturk, T, Koochek, A, et al. (2008) Effects of a short-term intervention with a Paleolithic diet in healthy volunteers. Eur J Clin Nutr 62, 682–685.
8. Ryberg, M, Sandberg, S, Mellberg, C, et al. (2013) A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women. J Intern Med 274, 67–76.
9. Smith, MM, Trexler, ET, Sommer, AJ, et al. (2014) Unrestricted Paleolithic diet is associated with unfavourable changes to blood lipids in healthy subjects. Int J Exerc Sci 7, 128–139.
10. Jönsson, T, Granfeldt, Y, Erlanson-Albertsson, C, et al. (2010) A Paleolithic diet is more satiating per calorie than a Mediterranean-like diet in individuals with ischemic heart disease. Nutr Metab 7, 85.
11. Keenan, MJ, Zhou, J, Hegsted, M, et al. (2015) Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr 6, 198–205.
12. Lockyer, S & Nugent, AP (2017) Health effects of resistant starch. Nutr Bull 42, 10–41.
13. Roberts, J, Jones, GP, Rutishauser, IHE, et al. (2004) Resistant starch in the Australian diet. Nutr Diet 61, 69–104.
14. Baghurst, PA, Baghurst, KI & Record, SJ (1996) Dietary fibre, non-starch polysaccharides and resistant starch – a review. Food Australia 48, Suppl., S1–S36.
15. Brown, JM & Hazen, SL (2014) Metaorganismal nutrient metabolism as a basis of cardiovascular disease. Curr Opin Lipidol 25, 48–53.
16. Wang, ZN, Klipfell, E, Bennett, BJ, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, U57–U82.
17. National Health and Medical Research Council, New Zealand Ministry of Health (2006) Nutrient reference values for Australia and New Zealand including recommended dietary intakes. https://www.nrv.gov.au/nutrients (accessed February 2018).
18. Skagen, K, Troseid, M, Ueland, T, et al. (2016) The carnitine–butyrobetaine–trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis 247, 64–69.
19. Tang, WHW, Wang, Z, Fan, Y, et al. (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol 64, 1908–1914.
20. Miller, CA, Corbin, KD, da Costa, KA, et al. (2014) Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose–response study. Am J Clin Nutr 100, 778–786.
21. Bae, S, Ulrich, CM, Neuhouser, ML, et al. (2014) Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study. Cancer Res 74, 7442–7452.
22. Norat, T, Bingham, S, Ferrari, P, et al. (2005) Meat, fish, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. J Natl Cancer Inst 97, 906–916.
23. Koeth, RA, Wang, ZE, Levison, BS, et al. (2013) Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19, 576–585.
24. Cho, CE, Taesuwan, S, Malysheva, OV, et al. (2017) Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res 61, 1600324.
25. Bergeron, N, Williams, PT, Lamendella, R, et al. (2016) Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk. Br J Nutr 116, 2020–2029.
26. Xyris Software (2015) FoodWorks Professional, 8.0 ed. QLD, Australia: Xyris Software.
30. Englyst, HN, Bingham, SA, Runswick, SA, et al. (1988) Dietary fibre (non-starch polysaccharides) in fruits, vegetables and nuts. J Hum Nutr Diet 1, 247–286.
31. Englyst, HN, Bingham, SA, Runswick, SA, et al. (1989) Dietary fibre (non-starch polysaccharides) in cereal products. J Hum Nutr Diet 2, 253–271.
33. IBM Corporation (2016) SPSS for Windows 22.214.171.124 ed. Chicago: IBM Corporation.
34. Cummings, JH, Macfarlane, GT & Englyst, HN (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 73, Suppl. 2, 415S–420S.
35. Topping, DL & Clifton, P (2001) Short chain fatty acids and human colonic function: roles of resistant starch and non-starch polysaccharides. Phys Rev 81, 1032–1064.
36. Brinkworth, GD, Noakes, M, Clifton, PM, et al. (2009) Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101, 1493–1502.
37. Conlon, MA & Bird, AR (2015) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7, 17–44.
38. David, LA, Maurice, CF, Carmody, RN, et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563.
39. Conlon, MA, Bird, AR, Clarke, JM, et al. (2015) Lowering of large bowel butyrate levels in healthy populations is unlikely to be beneficial. J Nutr 145, 1030–1031.
40. Charrier, JA, Martin, RJ, McCutcheon, KL, et al. (2013) High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize. Obesity (Silver Spring) 21, 2350–2355.
41. Gong, L, Cao, W, Chi, H, et al. (2018) Whole cereal grains and potential health effects: involvement of the gut microbiota. Food Res Int 103, 84–102.
42. Ley, R, Turnbaugh, PJ, Klein, S, et al. (2006) Human gut microbes associated with obesity. Nature 444, 1022–1023.
43. Ley, RE (2010) Obesity and the human microbiome. Curr Opin Gastroenterol 26, 5–11.
44. Ley, RE, Bäckhed, F, Turnbaugh, P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 11070–11075.
45. Wie, GA, Cho, YA, Kang, HH, et al. (2014) Red meat consumption is associated with an increased overall cancer risk: a prospective cohort study in Korea. Br J Nutr 112, 238–247.
47. Le Leu, RK, Winter, JM, Christophersen, CT, et al. (2015) Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial. Br J Nutr 114, 220–230.
48. Fuller, S, Beck, E, Salman, H, et al. (2016) New horizons for the study of dietary fiber and health: a review. Plant Foods Hum Nutr 71, 1–12.